Overview

To Explore the Safety and Efficacy of Hypidone Hydrochloride Tablets in Treatment of Patients With MDD

Status:
Completed
Trial end date:
2018-07-17
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and efficacy of Hypidone Hydrochloride tablets in treatment of patients with major depressive disorder (MDD) by evaluating the change of MADRS total score from baseline to week 6.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Shanghai Synergy Pharmaceutical Sciences Co., Ltd.
Zhejiang Huahai Pharmaceutical Co., Ltd.